SCHEMBL3395594

SCHEMBL3395594

CC(=O)N1CCN(c2ccc(-c3cnc4[nH]cc(CC(C)(C)C=O)c4n3)cc2)CC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP4K1 Q92918 2/20 0.44
FLT3 P36888 3/20 0.40
ALK Q9UM73 2/20 0.39
CDK1 P06493 1/20 0.39
CCNB1 P14635 1/20 0.39
CCNE1 P24864 1/20 0.39
CDK2 P24941 1/20 0.39
WNT3A P56704 3/20 0.39
CASP6 P55212 1/20 0.38
GFER P55789 1/20 0.38
SYK P43405 4/20 0.38
KDR P35968 1/20 0.38
MAPT P10636 2/20 0.38
USP2 O75604 1/20 0.38
TP53 P04637 1/20 0.38
MAPK1 P28482 1/20 0.38
HSD17B10 Q99714 1/20 0.38
PORCN Q9H237 1/20 0.38
DGAT1 O75907 1/20 0.37
MEN1 O00255 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3399404 0.91 MAP4K1 (0.45) MAP4K1ALKCDK2SYKDGAT1
SCHEMBL3394239 0.91 FLT3 (0.40) MAP4K1FLT3ALKCDK1CCNB1
SCHEMBL3398822 0.87 ITGB2 (0.39) FLT3ALKCDK1CCNB1CCNE1
SCHEMBL3395584 0.87 MAP4K1 (0.45) MAP4K1SYKMAPK1
SCHEMBL3396434 0.86 MAP4K1 (0.43) MAP4K1CDK2SYKKDRMAPT
SCHEMBL3400750 0.84 JAK3 (0.46) JAK3
SCHEMBL3399624 0.82 JAK3 (0.37) MAP4K1ALKSYKKDRMAPK1
SCHEMBL2281238 0.81 JAK3 (0.52) MAP4K1FLT3ALKCDK1CCNB1
SCHEMBL14655540 0.79 MAP4K1 (0.48) MAP4K1FLT3ALKCDK1CCNB1
SCHEMBL3398393 0.78 JAK3 (0.36) MAP4K1FLT3CDK1CCNB1CCNE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2245033-A1 PYRROLOPYRAZINE KINASE INHIBITORS F. Hoffmann-La Roche AG (CH) 2010-11-03 EP disclosed
WO-2009106441-A1 PYRROLOPYRAZINE KINASE INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2009-09-03 WO disclosed